Pharmaceutical companies develop system to better track counterfeit drugs
Share:
NEW YORK (Reuters) - Some of the industry's largest pharmaceutical companies, including Pfizer Inc and Eli Lilly and Co , have developed a blockchain-based system to track prescription drugs across the supply chain to better halt the flow of counterfeit medicines, company officials said on Friday.Some two dozen companies in the industry including drugmakers, distributers, retailers and delivery firms created the blockchain-based MediLedger Network, which it has been testing in the verification..